About Mozart Therapeutics
Mozart Therapeutics is developing CD8 Treg modulators for the treatment of autoimmune and inflammatory diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
mozart-tx.com
Domain Registered Date
Jun 24, 2020
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $25,000,000 · Series-A
fundraisingfox.com
- Capital Raise
Series-A announced
fundraisingfox.com
- Milestone
X account created (@Mozart_tx)
30 followers
- Milestone
Website domain registered
mozart-tx.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Mozart Therapeutics.
Funding History
Series-A
· Jun 7, 2023
$25,000,000 fundraisingfox.com
Series-A
· Oct 26, 2021
Undisclosed fundraisingfox.com
Founders & Leadership
Calvin Kuo
Scientific Co-Founder
Work email & phone locked
Unlock →
Gerald T. Nepom
Scientific Co-Founder
Work email & phone locked
Unlock →
K. Christopher Garcia
Scientific Co-Founder
Work email & phone locked
Unlock →
Mark Davis
Scientific Co-Founder
Work email & phone locked
Unlock →
Michael Rosenblum
Scientific Co-Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026